Price Chart
Key Statistics
Previous Close
$18.88Day Range
N/A52-Week Range
Avg Volume
1.2KDividend Yield
—Expense Ratio
0.70%AUM
$1.9MShares Outstanding
100.6KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 56.00% |
| Japan | 8.46% |
| Switzerland | 6.31% |
| Denmark | 4.37% |
| United Kingdom | 4.23% |
| Germany | 3.92% |
| Ireland | 3.85% |
| France | 3.81% |
| China | 3.62% |
| New Zealand | 1.95% |
| Netherlands | 1.86% |
| Australia | 1.13% |
| Other | 0.49% |
Fund Information
- Issuer
- First Trust
- Category
- Healthcare
- Types
- Medical Devices
- Inception Date
- Jun 22, 2021
- Exchange
- BATS
- Description
- The First Trust Indxx Medical Devices ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an index called the Indxx Medical Devices Index (the "Index"). The Fund will normally invest at least 80% of its net assets (including net assets plus any borrowings for investment purposes) in the common stocks and depositary receipts that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is developed, maintained and sponsored by Indxx, Inc. (the "Index Provider").
Similar ETFs
The First Trust Indxx Medical Devices ETF (MDEV) is an exchange-traded fund issued by First Trust that launched on Jun 22, 2021. It currently manages $1.9M in assets under management. The fund charges an expense ratio of 0.70%. The fund holds 52 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 24.6% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | WST | West Pharmaceutical Services, Inc. | 2.67% | 150 | $51K |
| 2 | LIVN | LivaNova Plc | 2.65% | 615 | $50K |
| 3 | DEMANT.DC | Demant A/S | 2.64% | 0 | $50K |
| 4 | BAX | Baxter International Inc. | 2.49% | 2,250 | $47K |
| 5 | DXCM | DexCom, Inc. | 2.44% | 603 | $46K |
| 6 | RVTY | Revvity, Inc. | 2.35% | 430 | $44K |
| 7 | A | Agilent Technologies, Inc. | 2.34% | 335 | $44K |
| 8 | WAT | Waters Corporation | 2.34% | 121 | $44K |
| 9 | 7733.JP | Olympus Corporation | 2.33% | 0 | $44K |
| 10 | STMN.SW | Straumann Holding AG (Registered) | 2.31% | 361 | $44K |
| 11 | EW | Edwards Lifesciences Corporation | 2.29% | 495 | $43K |
| 12 | SOON.SW | Sonova Holding AG (Registered) | 2.29% | 167 | $43K |
| 13 | TFX | Teleflex Incorporated | 2.27% | 326 | $43K |
| 14 | 4543.JP | Terumo Corporation | 2.20% | 0 | $42K |
| 15 | BIO | Bio-Rad Laboratories, Inc. (Class A) | 2.18% | 138 | $41K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | -0.35% | |
| 1M | +5.37% | |
| 3M | -0.85% | |
| 6M | -10.52% | |
| YTD | -10.37% | |
| 1Y | -7.75% | |
| 3Y | -10.13% | |
| 5Y | -25.49% |
Moving Averages
$18.72
Above 20-Day MA$18.85
Above 50-Day MA$20.12
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$21.81
Current Price
$18.86
52-Week Low
$17.85
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | MDEV | Healthcare(176 ETFs) | Medical Devices(7 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.70% | 0.61% | 0.44% |
| AUM | $1.9M | $910.0M | $6.11B |
| Dividend Yield | — | 3.35% | 0.80% |
| Avg Volume | 1.2K | 275.1K | 2.1M |
| Holdings | 52 | 99 | 55 |
| Performance | |||
| 1-Month Return | +3.96% | +1.77% | +4.48% |
| 6-Month Return | -11.28% | +3.26% | -4.99% |
| YTD Return | -10.30% | +3.61% | -4.60% |
| 1-Year Return | -8.12% | +24.59% | +1.76% |
Compare with Another ETF
Search for an ETF to compare with MDEV:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.